Creative Biolabs Pins a Can’t-Miss Webinar on Breakthrough EABR Nanoparticles & Hybrid mRNA Vaccines Creative Biolabs is excited to invite scientists, biotech professionals, and industry experts to an insightful upcoming webinar, „EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development”, presented by the renowned Dr. Magnus A.G. Hoffmann. „Scheduled for November 20, 2024, from 2 PM to 3 PM EST, this event promises to dive deep into hybrid mRNA vaccine technology, which is an innovative approach combining mRNA’s potency with advanced nanoparticle delivery mechanisms to enhance effectiveness,” a scientist at Creative Biolabs says. Webinar Highlights: EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development Attendees will get an exclusive look at the recent advancements made in hybrid mRNA vaccine technology and dive into breakthrough strategies for vaccine optimization. The webinar will cover: * The role of vaccines in combating pandemics and a comparison of current strategies, including the strengths and limitations of mRNA vaccines. * Development and benefits of hybrid mRNA technology, which combines mRNA instructions for protein synthesis with a protein-based nanoparticle delivery system, ensuring stability and targeted delivery. * In vivo testing insights for SARS-CoV-2 in animal models, including recent data on booster responses in previously vaccinated subjects. * Optimization techniques for enhanced hybrid mRNA vaccines, featuring early findings on novel designs that improve protein expression and immune response. * Hybrid mRNA vaccine applications for pan-coronavirus vaccines, offering a flexible platform adaptable to various coronavirus strains, thereby expanding the horizon of pandemic preparedness. Creative Biolabs Supports Every Angle of mRNA Research As the COVID-19 pandemic highlighted the need for rapid, adaptable vaccine solutions, mRNA technology has become a game-changer in immunology. Yet, in face of an ever-growing landscape of pathogens, scientists are racing to optimize mRNA vaccines to be even more versatile and effective, which is where hybrid mRNA technology, provided by CROs like Creative Biolabs, stands out, which provides advanced custom mRNA delivery vehicle development solutions. Their key business elements include: * Custom delivery vehicle discovery: maximize the stability, safety, and efficiency of mRNA therapeutics * Multiple delivery options available: lipid nanoparticles (LNPs), viral vectors, polymer-based carriers, and other advanced materials * Enhanced targeting and delivery: precise delivery to target cells and tissues * Application versatility: cancer immunotherapy, infectious disease vaccines, and gene therapy Beyond technical support, Creative Biolabs is committed to advancing mRNA vaccine research at every stage, from custom synthesis to sophisticated delivery systems, making it an invaluable resource for those tackling the complexities of modern immunotherapy. Upcoming Events In addition to the webinar, Creative Biolabs will be present at two other industry events before the year ends: * Scientist Solution Vendor Event – NIH 37 in December, where they will showcase their latest mRNA innovations and product offerings. * Antibody Engineering & Therapeutics (US) 2024 in December, a must-attend event for those involved in immunology and therapeutic antibody development. „This webinar is an unmissable opportunity to learn from a leading voice in hybrid mRNA vaccine technology,” the scientist says, „whether you’re an academic researcher, biotech professional, or pharmaceutical expert. Mark your calendar for November 20, 2024, at 2 PM EST and join us to stay at the forefront of vaccine development with Creative Biolabs.” About: https://mRNA.creative-biolabs.com/ About Creative Biolabs is a leading CRO specializing in innovative mRNA research solutions, offering custom synthesis, advanced delivery systems, and comprehensive support for mRNA vaccine and therapeutic development.
